FR2035775A1 - Immuno-chemical agent for selectively kil- - ling cancerous blood cells - Google Patents

Immuno-chemical agent for selectively kil- - ling cancerous blood cells

Info

Publication number
FR2035775A1
FR2035775A1 FR6907964A FR6907964A FR2035775A1 FR 2035775 A1 FR2035775 A1 FR 2035775A1 FR 6907964 A FR6907964 A FR 6907964A FR 6907964 A FR6907964 A FR 6907964A FR 2035775 A1 FR2035775 A1 FR 2035775A1
Authority
FR
France
Prior art keywords
blood cells
selectively
kil
ling
immuno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6907964A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST TECH GESUNDHEIT
Original Assignee
INST TECH GESUNDHEIT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST TECH GESUNDHEIT filed Critical INST TECH GESUNDHEIT
Priority to FR6907964A priority Critical patent/FR2035775A1/fr
Publication of FR2035775A1 publication Critical patent/FR2035775A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
FR6907964A 1969-03-19 1969-03-19 Immuno-chemical agent for selectively kil- - ling cancerous blood cells Withdrawn FR2035775A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR6907964A FR2035775A1 (en) 1969-03-19 1969-03-19 Immuno-chemical agent for selectively kil- - ling cancerous blood cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6907964A FR2035775A1 (en) 1969-03-19 1969-03-19 Immuno-chemical agent for selectively kil- - ling cancerous blood cells

Publications (1)

Publication Number Publication Date
FR2035775A1 true FR2035775A1 (en) 1970-12-24

Family

ID=9030921

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6907964A Withdrawn FR2035775A1 (en) 1969-03-19 1969-03-19 Immuno-chemical agent for selectively kil- - ling cancerous blood cells

Country Status (1)

Country Link
FR (1) FR2035775A1 (fr)

Similar Documents

Publication Publication Date Title
GB1253339A (en) Preparation of a prothrombin complex
CS186778B2 (en) Method for the separation of insoluble parts from coal solutions in liquefying agent
GB1356229A (en) Method for isolation of antithrombin from animal material
GB1303408A (fr)
GB1359232A (en) Liquid blood serum control standard
CA952799A (en) Method of determining hemoglobin in blood
CH550821A (de) Verfahren zur herstellung von 1,2,3,11b-tetrahydropyrido (3,4,5:m,n)thioxanthenen sowie von deren saeureadditionssalzen.
FR2035775A1 (en) Immuno-chemical agent for selectively kil- - ling cancerous blood cells
GB1288730A (fr)
GB1064633A (en) A diagnostic reagent
GB1286014A (en) Anti-tumour substance and process for producing the same
FI860350A (fi) Framstaellningsfoerfarande av gamma-globulin som laempar sig foer intravenoest ingivande.
GB1062434A (en) Process for isolating -antitrypsin
CH553218A (de) Verfahren zur herstellung von in c8-stellung modifizierten purinribofuranosid-3':5'-cyclophosphaten.
ES387885A1 (es) Metodo de preparacion de sulfato de condroitina.
US2847348A (en) Plasma fractionation and product therefrom
GB1229570A (fr)
IE38688L (en) Purification of orgotein
SU412765A1 (ru) Способ получени -пуринил- диамидопуринилфосфонилмочевины
Hathaway Fibrin split products in serum of newborn: possible technical errors
Taoka et al. Early effects of protein depletion on hepatic glycoprotein synthesis in the rat
FR2047889A1 (en) Fibrinolytic enzyme separation from mould - fungus cultures
GB1551792A (en) Process for manufacturing tin-containing serum albumin particles suitable for binding technetium
GB1304483A (fr)
GB1244277A (en) Isolation of orgotein from blood

Legal Events

Date Code Title Description
ST Notification of lapse